First Yaz Case Will Involve Pulmonary Embolism
As previously reported, the first "bellwether" case in the Yaz / Yasmin Multi-District Litigation will involve a woman who suffered a pulmonary embolism. Because so many of the women who have sued Bayer after using Yaz and Yasmin, suffered from serious blood clots, including deep vein thrombosis, pulmonary embolism and stroke, Judge Herndon in Illinois ordered that the first bellwether case should involve one of these injuries.
A pulmonary embolism occurs when one or more arteries in your lungs become blocked. Most often, pulmonary embolism is caused by blood clots that travel from your legs (deep vein thrombosis) to your lungs. Sometimes, pulmonary embolism can be fatal. About one-third of people with undiagnosed and untreated pulmonary embolism die. Fortunately, treatment for pulmonary embolism, including use of blood thinners, decreases this risk significantly.
Risk factors for pulmonary embolism include: prolonged immobility (e.g. long plane rides or car trips); age (older people are at a higher risk of developing clots); family history; recent surgery; medical conditions (heart disease, cancer); smoking, being overweight; and taking estrogen (as is included in combination oral contraceptives such as Yaz, Yasmin, Ocella and Zarah).
Our attorneys represent hundreds of women who have suffered serious injuries after taking Yaz, Yasmin, and Ocella. Many of these women were diagnosed with serious blood clots including deep vein thrombosis, pulmonary embolism,
stroke and even death. Our
Yaz / Yasmin lawyers will be involved in helping prepare Yaz / Yasmin bellwether cases for trial, including those involving venous thrombotic events, such as deep vein thrombosis, pulmonary embolism and stroke.
Categories:
Yaz, Yasmin, Yaz lawsuit, Yasmin lawsuit, Venous thromboembolism, stroke, deep vein thrombosis, Pulmonary embolism, MDL, Ocella, Yaz lawyer, Yaz attorney, Yasmin lawyer, Yasmin attorney, side effects, bellwether trials